Semaglutide While Trying to Conceive: Timing and Safety

For women using semaglutide to lose weight, the question of how it intersects with pregnancy planning is one of the most important conversations to have with a provider. Whether you’re actively trying to conceive, thinking about it in the next year, or simply want to understand your options, the guidance here is more nuanced than a simple yes or no. Semaglutide can play a meaningful role in preparing your body for pregnancy, but the timing of when to stop, how long to wait, and what to expect during the gap matters significantly.

The Core Safety Position

Semaglutide is contraindicated during pregnancy. This applies to all forms of semaglutide, including Ozempic, Wegovy, and compounded semaglutide. The FDA labeling for both Ozempic and Wegovy explicitly states that the medication should be discontinued before a planned pregnancy, and that women who become pregnant while taking semaglutide should stop immediately and contact their provider.

The basis for this contraindication is animal study data showing fetal harm at doses producing exposures comparable to human therapeutic levels. In animal models, semaglutide caused reduced fetal growth, skeletal abnormalities, and increased pregnancy loss. Human pregnancy data on semaglutide remains limited because the medication is relatively new and clinical trials appropriately excluded pregnant participants.

The animal findings don’t automatically predict human outcomes, but they establish a sufficient safety concern that the precautionary approach applies until robust human data exists. That data is slowly accumulating through pregnancy registries, but it will be years before population-level conclusions are possible.

How Long Before Trying to Conceive Should You Stop

This is the question most women want a precise answer to, and the honest answer is that the guidance varies somewhat depending on the source and continues to evolve as more data emerges.

Semaglutide has a half-life of approximately seven days, meaning it takes roughly five half-lives, about five weeks, for the drug to be substantially cleared from circulation. However, most clinical guidance recommends stopping semaglutide at least two months before attempting conception. Some providers and medical organizations suggest a longer washout period of up to two to three months to account for individual variation in clearance and the critical sensitivity of early embryonic development.

The two-month minimum is not arbitrary. Early pregnancy, particularly the period from conception through the first eight weeks when major organ systems are forming, represents the window of greatest vulnerability to any medication exposure. Waiting until the medication is well cleared before conception attempts reduces the risk of any overlap between active drug levels and early fetal development.

The practical implication is that if you’re planning to try to conceive in six months, the conversation with your provider about stopping semaglutide should happen now, not in five months. Planning the washout period deliberately is far better than stopping abruptly when conception becomes imminent. For broader context on how GLP-1 medications intersect with fertility planning, GLP-1 Medications and Fertility covers the full picture.

What Happens to Your Weight During the Washout Period

This is where many women feel caught between competing concerns. They’ve worked hard to lose weight on semaglutide, they know stopping means some regain is likely, and they don’t want to enter pregnancy at a higher weight than necessary.

The evidence on what happens after stopping semaglutide is consistent: most people regain a portion of the weight they lost, and the regain begins relatively quickly after the medication clears. Studies suggest that without behavioral and dietary strategies in place, patients can regain roughly half of their lost weight within a year of stopping.

However, the goal isn’t to maintain your lowest treatment weight through the washout period and into pregnancy. The goal is to enter pregnancy at a meaningfully healthier weight than you would have without semaglutide treatment, and to have built the dietary habits and metabolic improvements that support a healthy pregnancy even without the medication.

Women who lose 10–20% of their body weight on semaglutide before stopping have typically reduced visceral fat, improved insulin sensitivity, and lowered their metabolic risk profile in ways that persist beyond the medication itself, at least partially. Some regain is expected, but the metabolic baseline is better than it was before treatment. What Happens When You Stop Taking Semaglutide covers the full picture of what to expect after stopping.

Strategies that help minimize regain during the washout period include maintaining high protein intake, continuing resistance training, managing portion sizes deliberately without the appetite suppression the medication provided, and working with a provider or dietitian on a transition plan. Building Lasting Habits After Stopping GLP-1 Medications offers practical guidance for exactly this transition.

If You Become Pregnant While Still on Semaglutide

Unintended pregnancies occur, and some women discover they’re pregnant before they’ve had a chance to complete a planned washout period, or without having planned to conceive at all. If you get a positive pregnancy test while still taking semaglutide, stop the medication immediately and contact your healthcare provider the same day.

Your provider will likely refer you to an OB-GYN or maternal-fetal medicine specialist who can assess the timing of your last dose relative to conception, discuss what monitoring is appropriate, and advise on next steps. Novo Nordisk maintains a pregnancy registry for semaglutide exposure, and enrollment may be recommended to contribute to the growing body of safety data.

A positive test while on semaglutide is not a reason for panic. It is a reason for prompt action and specialist involvement.

Oral Contraceptives and Semaglutide: A Practical Note

Women on semaglutide who are not yet ready to conceive need to be aware of a potential interaction with oral contraceptive pills. Semaglutide slows gastric emptying, which can affect the absorption of oral medications including birth control pills. The concern is that delayed or reduced absorption could theoretically lower contraceptive hormone levels and reduce effectiveness.

Current guidance suggests that women on oral contraceptives who start semaglutide may want to use additional contraceptive methods, particularly during the first four weeks of semaglutide treatment and after any dose increase. Barrier methods, IUDs, or other non-oral contraceptive options are not affected by gastric emptying and don’t carry this concern. This is a conversation worth having explicitly with your provider, particularly if pregnancy prevention is important during your treatment period.

How Semaglutide Can Support Fertility Before You Stop

Here’s the aspect of the semaglutide and fertility conversation that often gets overlooked: used thoughtfully before conception attempts begin, semaglutide can actively improve the conditions for a healthy pregnancy.

Obesity and insulin resistance are significant drivers of infertility in women, particularly through their effects on PCOS, menstrual irregularity, and ovulation. Women with PCOS who achieve meaningful weight loss through semaglutide treatment often see improvements in menstrual regularity, ovulation frequency, and hormonal markers of reproductive function before they stop the medication. For women specifically dealing with PCOS, Ozempic for PCOS covers what the evidence shows.

Beyond PCOS, reducing visceral fat and improving insulin sensitivity through semaglutide treatment creates a metabolic environment that is more favorable for conception and early pregnancy. Women with gestational diabetes in a previous pregnancy may reduce their risk in a subsequent pregnancy by entering it at a lower weight with better glucose metabolism. The broader evidence on weight loss and fertility is covered in Losing Weight Before Pregnancy.

Postpartum: When Can You Restart Semaglutide

After delivery, many women want to know when they can restart semaglutide, particularly if they experienced significant postpartum weight gain or are trying to return to the weight they achieved during treatment.

For women who are not breastfeeding, there is no specific contraindication to restarting semaglutide after the postpartum recovery period, typically once cleared by their provider at the six-week postpartum visit or later.

For breastfeeding women, the situation requires more caution. There is currently no adequate human data on semaglutide levels in breast milk or what effect infant exposure might have. Most providers recommend waiting until breastfeeding is complete before restarting. Breastfeeding and GLP-1 covers the current guidance across GLP-1 medications for nursing mothers.

Having a Proactive Conversation With Your Provider

The women who navigate the semaglutide and fertility intersection most successfully are those who plan ahead rather than reacting to circumstances. If you’re on semaglutide and pregnancy is on your horizon in any timeframe, the conversation with your provider should cover the planned washout period and its timing, contraceptive strategy during treatment, weight management strategies for the gap between stopping and conceiving, and postpartum restart planning.

These aren’t complicated conversations, but they require some lead time to manage well. Stopping semaglutide two months before trying to conceive means making that decision at least two months in advance, which requires planning.

If you’re considering semaglutide and want to understand how it fits with your reproductive health goals before you start, start your assessment at TrimRx and connect with a clinician who can help you build a plan that accounts for both your weight management goals and your family planning timeline.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.